Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BioSig Technologies, Inc. (BSGM)
|
Add to portfolio |
|
|
|
| Price: |
$2.44
| | Metrics |
| OS: |
74.9
|
M
| |
|
|
| Market cap: |
$183
|
M
| |
|
|
|
Net cash:
|
$1.3
|
M
| |
$0.02
|
per share
|
|
EV:
|
$182
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($26.8)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | 0.0 |
| Revenue growth | -35.1% | | | | | -100.0% | | -100.0% |
| Cost of goods sold | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 11.2 | 0.0 |
| Gross profit | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | -8.5 | 0.0 |
| Gross margin | 80.1% | 54.9% | | | | | -320.6% | |
| Research and development | 5.8 | 5.6 | 18.1 | 9.7 | 4.4 | 4.8 | | 1.5 |
| General and administrative | 21.4 | 27.9 | 41.0 | 24.8 | 12.9 | 8.1 | 8.5 | 10.5 |
| EBIT | -27.3 | -33.4 | -59.2 | -34.6 | -17.3 | -12.9 | -11.2 | -12.0 |
| EBIT margin | -9533.2% | -7576.2% | | | | | -420.6% | |
| Pre-tax income | -27.3 | -32.9 | -59.1 | -34.5 | -17.3 | -12.7 | -11.6 | -9.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -27.3 | -31.9 | -52.2 | -34.1 | -18.1 | -12.8 | -11.7 | -9.8 |
| Net margin | -9535.3% | -7239.5% | | | | | -440.7% | |
| |
| Diluted EPS | ($0.64) | ($0.95) | ($1.87) | ($1.65) | ($1.25) | ($1.25) | ($0.60) | ($0.70) |
| Shares outstanding (diluted) | 42.6 | 33.5 | 27.9 | 20.7 | 14.5 | 10.2 | 19.5 | 14.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|